Baumal Caroline 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
Baumal Caroline
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-01-06$33.81/sh−2,816$95,215→ 55,560.37 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/03/2025.